Scientific Effect
This fermented product, Red Yeast Rice, has long been used to reduce cholesterol. Supplementation can improve cardiovascular health and reduce fatigue.
Clinical Study
A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial.
Results
"Red yeast rice-olive extract significantly reduced lipoprotein-associated phospholipase A2 in correlation with the marked reduction in plasma oxidised low-density lipoprotein, which may lead to a reduced risk for cardiovascular disease in patients with metabolic syndrome."
Study Citation
Hermans, N., Van der Auwera, A., Breynaert, A., Verlaet, A., De Bruyne, T., Van Gaal, L., ... & Verhoeven, V. (2017). A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA 2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial. Trials, 18(1), 302.
LinkClinical Study
Red yeast rice and therapeutic lifestyle change decrease LDL cholesterol level without increasing CPK or pain levels and may be a treatment option for dyslipidemic patients who cannot tolerate statin therapy.
Results
"Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial."
Study Citation
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
LinkClinical Study
Among dyslipidemic patients with low to moderate cardiovascular risk, red yeast rice induced less fatigue side effect and exerted comparable lipid-lowering effects when compared to simvastatin in this pilot primary prevention study.
Results
"Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial."
Study Citation
Xue, Y., Tao, L., Wu, S., Wang, G., Qian, L., Li, J., ... & Ji, K. (2017). Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial. BMC cardiovascular disorders, 17(1), 127.
Link